Dan Leonard
Stock Analyst at UBS
(3.85)
# 693
Out of 4,989 analysts
289
Total ratings
54.22%
Success rate
8.17%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $12.49 | +4.08% | 6 | Aug 8, 2025 | |
| EXAS Exact Sciences | Maintains: Neutral | $61 → $53 | $52.41 | +1.13% | 10 | Aug 7, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $300 → $305 | $496.14 | -38.53% | 2 | Jul 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $460 → $500 | $469.75 | +6.44% | 17 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Buy | $240 → $225 | $189.72 | +18.60% | 18 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $185 → $225 | $186.45 | +20.68% | 16 | Jul 23, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,257.03 | +7.40% | 9 | May 20, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $52.92 | +32.28% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $33.31 | +35.09% | 11 | May 8, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $282.07 | +9.90% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $310 | $286.40 | +8.24% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $70 | $59.72 | +17.21% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $145 → $115 | $85.71 | +34.17% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $122 → $99 | $94.39 | +4.88% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $12.24 | +104.25% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $150.25 | +23.13% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $9.81 | -8.26% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $21.94 | +59.53% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $125.94 | +19.10% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $99.37 | +101.27% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.74 | +301.46% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $172.83 | -59.50% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $13.93 | -49.75% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $299.22 | +15.30% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $170.38 | +52.60% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $186.97 | -22.45% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $67.64 | +33.06% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $45.61 | +39.55% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $279.94 | +21.45% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $26.90 | -10.78% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $7.70 | +354.55% | 12 | Aug 14, 2019 |
10x Genomics
Aug 8, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.49
Upside: +4.08%
Exact Sciences
Aug 7, 2025
Maintains: Neutral
Price Target: $61 → $53
Current: $52.41
Upside: +1.13%
Medpace Holdings
Jul 29, 2025
Downgrades: Sell
Price Target: $300 → $305
Current: $496.14
Upside: -38.53%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Neutral
Price Target: $460 → $500
Current: $469.75
Upside: +6.44%
Danaher
Jul 23, 2025
Maintains: Buy
Price Target: $240 → $225
Current: $189.72
Upside: +18.60%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $185 → $225
Current: $186.45
Upside: +20.68%
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,257.03
Upside: +7.40%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $52.92
Upside: +32.28%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $33.31
Upside: +35.09%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $282.07
Upside: +9.90%
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $286.40
Upside: +8.24%
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $59.72
Upside: +17.21%
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $85.71
Upside: +34.17%
Apr 7, 2025
Maintains: Overweight
Price Target: $122 → $99
Current: $94.39
Upside: +4.88%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $12.24
Upside: +104.25%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $150.25
Upside: +23.13%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $9.81
Upside: -8.26%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $21.94
Upside: +59.53%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $125.94
Upside: +19.10%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $99.37
Upside: +101.27%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.74
Upside: +301.46%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $172.83
Upside: -59.50%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $13.93
Upside: -49.75%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $299.22
Upside: +15.30%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $170.38
Upside: +52.60%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $186.97
Upside: -22.45%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $67.64
Upside: +33.06%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $45.61
Upside: +39.55%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $279.94
Upside: +21.45%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $26.90
Upside: -10.78%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $7.70
Upside: +354.55%